genomiQa brings precision whole genome analytics to routine clinical practice – making whole genome sequencing the norm, not the exception.
Helping clinicians select the best treatment
CapeDx is the most comprehensive cancer genomic test in the world and will be available in Australia in mid-2020.
Simplifying the diagnostic odyssey
Whole genome sequencing and analysis to help patients and their families quickly diagnose potential genetic diseases. Available in Australia late-2020.
Bringing whole-genome analysis to clinical research
genomiQa is a world leader in implementing whole genome analysis. We can help discover the genomic determinants of response for your new drug to develop novel biomarkers and companion diagnostics.